Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

923
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
923
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

149
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
149
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.3K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A single biomarker may not yield a reliable binary clinical answer: B cell lymphoma 6 testing and resulting interventions for endometriosis in infertility care.

F&S reports·2026
Same author

High-Resolution Spatial Transcriptomics Reveals Fibroblast and Neuroimmune Microenvironments in Endometriosis Lesions.

bioRxiv : the preprint server for biology·2025
Same author

Author Correction: Single-cell analysis of endometriosis reveals a coordinated transcriptional programme driving immunotolerance and angiogenesis across eutopic and ectopic tissues.

Nature cell biology·2022
Same author

Single-cell analysis of endometriosis reveals a coordinated transcriptional programme driving immunotolerance and angiogenesis across eutopic and ectopic tissues.

Nature cell biology·2022
Same author

Medical management of endometriosis.

Minerva obstetrics and gynecology·2021
Same author

Understanding Barriers to Contraception Screening and Referral in Female Adolescents and Young Adults with Cancer.

Journal of adolescent and young adult oncology·2019
Same journal

σ<sub>1</sub> receptor agonists: the new trend or an emerging therapeutic option?

Expert opinion on emerging drugs·2026
Same journal

Obefazimod (ABX464) for moderate-to-severe Crohn's disease: clinical development of a novel oral therapeutic approach.

Expert opinion on emerging drugs·2026
Same journal

Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease.

Expert opinion on emerging drugs·2026
Same journal

Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond.

Expert opinion on emerging drugs·2026
Same journal

Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies.

Expert opinion on emerging drugs·2026
Same journal

Acute management of adult MOG antibody-associated disease: therapeutic choices and clinical outcomes.

Expert opinion on emerging drugs·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

16.1K

Emerging therapy for endometriosis.

Sarah F Lindsay1, Danielle E Luciano, Anthony A Luciano

  • 1a 1 University of Connecticut School of Medicine, Department of Obstetrics and Gynecology , 263 Farmington Avenue, Farmington, CT 06303-2947, USA.

Expert Opinion on Emerging Drugs
|June 9, 2015
PubMed
Summary
This summary is machine-generated.

Endometriosis management requires chronic suppressive therapy. Newer medical treatments like gonadotropin-releasing antagonists offer potential alternatives for endometriosis pain and infertility.

Keywords:
aromatase inhibitorcombined hormonal contraceptiveendometriosisgonadotropin-releasing hormone agonistgonadotropin-releasing hormone antagonistlevonorgesterol intrauterine systemnonsteroidal anti-inflammatory drugprogesterone antagonistprogestinsselective estrogen receptor modulatorselective progesterone receptor modulatorvascular endothelial growth factor

More Related Videos

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
08:16

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

8.9K
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:07

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 11, 2026

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

16.1K
Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis
08:16

Noninvasive Monitoring of Lesion Size in a Heterologous Mouse Model of Endometriosis

Published on: February 26, 2019

8.9K
Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
08:07

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility

Published on: April 5, 2024

1.7K

Area of Science:

  • Gynecology
  • Reproductive Medicine
  • Medical Therapy

Background:

  • Endometriosis is a chronic inflammatory disease causing pain and infertility.
  • Ectopic endometrial tissue implantation leads to significant healthcare resource utilization.
  • Current management necessitates long-term treatment and repeated interventions.

Purpose of the Study:

  • To review available medical therapies for endometriosis.
  • To discuss limitations of current endometriosis treatments.
  • To explore emerging therapies for improved patient outcomes.

Main Methods:

  • Literature review of medical therapies for endometriosis.
  • Analysis of treatment efficacy, side effects, and duration of relief.
  • Evaluation of novel therapeutic agents and their potential.

Main Results:

  • Existing medical therapies for endometriosis pain have limitations including side effects and cost.
  • No single therapy is effective or well-tolerated by all patients.
  • Chronic suppressive therapy is recommended, especially postoperatively.

Conclusions:

  • Effective, well-tolerated, long-term medical therapies are crucial for endometriosis.
  • Gonadotropin-releasing antagonists and aromatase inhibitors show promise.
  • Combination therapies may offer improved alternatives for endometriosis management.